| Literature DB >> 35497070 |
Meruyert I Tleubayeva1, Raisa M Abdullabekova2, Ubaidilla М Datkhayev1, Margarita Yu Ishmuratova3, Mereke B Alimzhanova4, Kaldanay K Kozhanova1, Aida M Seitaliyeva5, Kairat S Zhakipbekov1, Zhanar B Iskakova6, Elmira A Serikbayeva1, Elena V Flisyuk7.
Abstract
Medicinal plants remain as an important resource in the fight against many diseases, especially in developing countries. Antioxidants are substances capable of delaying, retarding, and preventing the oxidation of lipids or substances that delay or prevent free radical reactions during lipid oxidation. Natural antioxidants such as ascorbic acid, tocopherol, phenolic compounds, and flavonoids are a safe alternative to chemical antioxidants. In present work, results of antioxidant activity of raw materials from the cultivated plant Portulaca oleracea are presented. The extraction time was optimized to 780 minutes; the yield of extractive substances was 1.25% in the production of CO2 extract under subcritical conditions. For the first time, the antioxidant activity of Portulaca oleracea CO2 extract was determined by the amperometric method. Gas chromatography-mass spectrometry (GC-MS) chemical analysis of Portulaca oleracea CO2 extract dissolved in hexane revealed 37 components, including a complex mixture of aldehydes, alkanes, alkenes, esters, diterpenes, steroids, vitamin E, and carbohydrates. The investigation results showed that the Portulaca oleracea CO2 extract was promising for pharmaceutical, cosmetic, and food industries and had great potential for the prevention and treatment of diseases caused by oxidative stress.Entities:
Year: 2022 PMID: 35497070 PMCID: PMC9054492 DOI: 10.1155/2022/6478977
Source DB: PubMed Journal: Int J Biomater ISSN: 1687-8787
The results of chromatographic analysis of Portulaca olеracea CO2 extract.
| No. | Retention time (min) | Compound | Identification probability (%) | Percentage (%) | Groups of biological active compounds |
|---|---|---|---|---|---|
| 1 | 11.0 | 4-Cyclopentene-1, 3-dione | 84 | 0.79 | Ketone |
| 2 | 12.6 | 4-Hydroxy-butanoic acid | 93 | 0.46 | Butyrolactone |
| 3 | 12.8 | 1-Butene, 4-isothiocyanato- | 85 | 0.32 | Isothiocyanic acid, 3-butenyl ester |
| 4 | 13.5 | 1-(1'-Pyrrolidinyl)-2-propanone | 95 | 0.99 | Ketone |
| 5 | 14.6 | 1-Amino-2,6-dimethylpiperidine | 67 | 0.27 | Piperidine derivative |
| 6 | 15.8 | 2,5-Dimethyl-4-hydroxy-3(2H)-furanone | 77 | 0.26 | Ketone |
| 7 | 16.9 | 4H-Pyran-4-one, 2,3-dihydro-3, 5-dihydroxy-6-methyl- | 90 | 2.44 | Pyran derivative |
| 8 | 17.5 | Benzyl nitrile | 93 | 1.21 | Benzene derivatives |
| 9 | 18.5 | Benzofuran, 2,3-dihydro-1- | 80 | 1.06 | Benzofuran derivatives |
| 10 | 20.4 | 2-Methoxy-4-vinylphenol | 93 | 2.07 | Phenol |
| 11 | 20.7 | Pyrazine, 2-ethyl-5-methyl- | 85 | 0.96 | Pyrazine derivative |
| 12 | 22.8 | Pyrrolidine, 1-(1-cyclohexen-1-yl)- | 71 | 0.94 | Pyrrolidine derivative |
| 13 | 23.2 | 4-(2, 6, 6-Trimethylcyclohexa-1, 3-dienyl)but-3-en-2-one | 78 | 0.39 | Steroid |
| 14 | 25.1 | Sucrose | 72 | 10.85 | Carbohydrate |
| 15 | 26.0 | Phosphonofluoridic acid, (1-methylethyl)-, cyclohexyl ester | 70 | 1.43 | Ester |
| 16 | 26.2 | 3', 5'-Dimethoxyacetophenone | 76 | 1.85 | Ketone |
| 17 | 26.9 | Megastigmatrienone | 75 | 0.21 | Steroid |
| 18 | 27.4 | 3, 7, 11, 15-Tetramethyl-2-hexadecen-1-ol | 80 | 1.31 | Alcohol |
| 19 | 29.0 | Imidazolo [1,2-a] pyrimidine-2,5(1H,3H)-dione, 3,7-dimethyl- | 65 | 0.36 | Ketone |
| 20 | 30.6 | 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol | 82 | 0.76 | Phenol |
| 21 | 31.2 | Benzoic acid, 4-hydroxy-3, 5-dimethoxy-, hydrazide | 91 | 2.21 | Heterocyclic compound |
| 22 | 31.5 | Phthalic acid, isobutyl octadecyl ester | 64 | 3.03 | Ester |
| 23 | 32.5 | Octahydro-2(1H)-quinolinone | 66 | 1.70 | Ketone |
| 24 | 33.8 | Phytol | 76 | 5.80 | Diterpene |
| 25 | 34.1 | Linoleic acid ethyl ester | 72 | 0.69 | Ester |
| 26 | 35.6 | Desulphosinigrin | 70 | 16.96 | Carbohydrate |
| 27 | 36.6 | 5, 10-Diethoxy-2, 3, 7, 8-tetrahydro-1H,6H-dipyrrolo[1,2-a:1',2'-d]pyrazine | 71 | 0.47 | Pyrazine derivative |
| 28 | 39.0 | Heneicosane | 87 | 0.81 | Alkane |
| 29 | 40.6 | Heptacosane | 80 | 0.68 | Alkane |
| 30 | 41.4 | 2-Methylhexacosane | 84 | 1.02 | Alkane |
| 31 | 42.1 | Hexacosane | 93 | 20.67 | Alkane |
| 32 | 43.6 | Octacosane | 91 | 1.85 | Alkane |
| 33 | 46.4 | Tetratetracontane | 79 | 1.31 | Alkane |
| 34 | 48.7 | Octacosanol | 74 | 2.67 | Alcohol |
| 35 | 50.9 | Vitamin E | 95 | 6.42 | Derivative of tocol |
| 36 | 54.7 |
| 90 | 3.78 | Steroid |
| 37 | 55.3 | Phytol, acetate | 70 | 0.96 | Ester |
Chromatographic analysis of the hexane fraction of Portulaca olеracea CO2 extract.
| No. | Retention time (min) | Compound | Identification probability (%) | Percentage (%) |
|---|---|---|---|---|
| 1 | 12.7 | 2, 4-Heptadienal | 89 | 0.96 |
| 2 | 14.4 | Nonanal | 91 | 0.22 |
| 3 | 15.8 | 2, 5-Furandione, 3-(1,1-dimethylethyl)- | 88 | 0.27 |
| 4 | 16.1 | Cyclohexanol, 1-methyl-4-(1-methylethyl)- | 83 | 0.54 |
| 5 | 16.3 | Octanoic acid | 90 | 0.92 |
| 6 | 16.4 | Cyclodecene | 73 | 0.24 |
| 7 | 18.2 | Nonanoic acid | 87 | 1.45 |
| 8 | 18.7 | Tetradecane | 85 | 0.31 |
| 9 | 19.1 | 2, 4-Decadienal | 87 | 0.67 |
| 10 | 19.4 | Alfa-copaene | 93 | 0.26 |
| 11 | 20.0 | Decanoic acid | 72 | 1.44 |
| 12 | 20.6 | Caryophyllene | 93 | 0.43 |
| 13 | 21.0 | Undecanoic acid | 84 | 0.40 |
| 14 | 21.9 | 5,9-Undecadien-2-one, 6,10-dimethyl- | 85 | 0.38 |
| 15 | 22.5 | Hexadecane | 90 | 0.33 |
| 16 | 22.8 |
| 73 | 0.30 |
| 17 | 23.0 | trans- | 90 | 0.28 |
| 18 | 23.2 | 3-Buten-2-one, 4-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)- | 74 | 0.24 |
| 19 | 23.2 | Vanillin | 75 | 0.19 |
| 20 | 24.0 | Nonanoic acid, 9-oxo-, ethyl ester | 85 | 0.31 |
| 21 | 24.4 | Heptadecane | 82 | 0.36 |
| 22 | 25.6 | Tridecanoic acid | 83 | 0.28 |
| 23 | 26.0 | 2(4H)-Benzofuranone, 5, 6, 7, 7a-tetrahydro-4,4,7a-trimethyl-, (R)- | 74 | 0.82 |
| 24 | 26.1 | Hexadecane, 2,6,10,14-tetramethyl- | 69 | 0.15 |
| 25 | 26.3 | Octadecane | 89 | 0.25 |
| 26 | 26.5 | Hexadecanal | 82 | 0.28 |
| 27 | 27.4 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 84 | 0.45 |
| 28 | 28.3 | Nonadecane | 89 | 0.34 |
| 29 | 28.6 | 2-Pentadecanone, 6, 10, 14-trimethyl- | 93 | 2.87 |
| 30 | 29.9 | Benzoic acid, undecyl ester | 66 | 0.30 |
| 31 | 30.3 | Hexadecanoic acid, methyl ester | 75 | 0.39 |
| 32 | 30.7 | 1,4-Naphthalenedione, 2, 3, 6-trimethyl- | 71 | 0.50 |
| 33 | 31.1 | 5, 9, 13-Pentadecatrien-2-one, 6, 10, 14-trimethyl-, (E,E)- | 87 | 0.53 |
| 34 | 31.2 | Benzoic acid, 4-hydroxy-3, 5-dimethoxy-, hydrazide | 86 | 0.35 |
| 35 | 33.9 | Phytol | 94 | 11.87 |
| 36 | 34.4 |
| 68 | 1.96 |
| 37 | 35.1 | Ethyl oleate | 91 | 5.73 |
| 38 | 38.6 | Methyl 19-methyl-eicosanoate | 68 | 2.69 |
| 39 | 39.3 | 4,8,12,16-Tetramethylheptadecan-4-olide | 86 | 1.53 |
| 40 | 41.8 | Docosanoic acid, ethyl ester | 75 | 0.97 |
| 41 | 42.6 | 13-Methylheptacosane | 74 | 1.59 |
| 42 | 49.9 |
| 60 | 2.56 |
| 43 | 51.0 | Vitamin E | 93 | 17.62 |
| 44 | 52.0 | Phytol, acetate | 84 | 2.83 |
| 45 | 53.2 | Campesterol | 91 | 4.54 |
| 46 | 53.7 | Stigmasterol | 83 | 2.86 |
| 47 | 54.9 |
| 91 | 20.65 |
| 48 | 55.4 | Phytol, acetate | 85 | 4.63 |
Figure 1The ratio of the groups of biologically active substances of the hexane fraction of the Portulaca olеracea CO2 extract.
Chromatographic analysis of the dichloromethane fraction of the Portulaca olеracea CO2 extract.
| No. | Retention time (min) | Compound | Identification probability (%) | Percentage (%) |
|---|---|---|---|---|
| 1 | 26.0 | 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl- | 78 | 1.00 |
| 2 | 27.4 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 81 | 0.44 |
| 3 | 27.7 | Tetradecanoic acid, ethyl ester | 89 | 0.99 |
| 4 | 28.5 | 3-Buten-2-one, 4-(4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)- | 73 | 0.77 |
| 5 | 28.6 | 2-Pentadecanone, 6,10,14-trimethyl- | 92 | 2.33 |
| 6 | 33.8 | Phytol | 94 | 15.32 |
| 7 | 34.3 |
| 67 | 2.52 |
| 8 | 35.0 | Ethyl oleate | 88 | 7.15 |
| 9 | 38.1 | Hexadecanoic acid, 1-(hydroxymethyl)-1,2-ethanediyl ester | 65 | 0.62 |
| 10 | 38.6 | Methyl 19-methyl-eicosanoate | 68 | 1.36 |
| 11 | 39.2 | 4,8,12,16-Tetramethylheptadecan-4-olide | 90 | 1.97 |
| 12 | 43.2 | Hexacosane, 9-octyl- | 80 | 4.18 |
| 13 | 45.2 | Squalene | 86 | 5.73 |
| 14 | 49.9 |
| 66 | 3.28 |
| 15 | 50.9 | Vitamin E | 95 | 21.22 |
| 16 | 53.2 | Campesterol | 84 | 4.51 |
| 17 | 54.7 |
| 92 | 22.75 |
| 18 | 55.3 | Phytol, acetate | 75 | 3.86 |
Figure 2The ratio of the main groups of biologically active substances of the Portulaca oleracea dichloromethane fraction.
Chromatographic analysis of the ethyl acetate fraction of the Portulaca оlеracea CO2 extract.
| No. | Retention time (min) | Compound | Identification probability (%) | Percentage (%) |
|---|---|---|---|---|
| 1 | 28.61 | 2-Pentadecanone, 6,10,14-trimethyl- | 89 | 2.71 |
| 2 | 29.90 | Benzoic acid, hept-2-yl ester | 64 | 1.90 |
| 3 | 30.36 | Benzoic acid, pentadecyl ester | 78 | 4.05 |
| 4 | 31.43 | Hexadecanoic acid | 85 | 9.46 |
| 5 | 31.85 | Methyl 8,11,14-heptadecatrienoate | 82 | 2.15 |
| 6 | 33.76 | Phytol | 67 | 10.85 |
| 7 | 34.99 | Ethyl oleate | 88 | 7.14 |
| 8 | 50.92 | DL- | 86 | 29.69 |
| 9 | 53.17 | Campesterol | 74 | 5.32 |
| 10 | 54.68 |
| 88 | 26.73 |
Figure 3The ratio of the main groups of biologically active compounds of the Portulaca oleracea ethyl acetate fraction.
Chromatographic analysis of the methanol fraction of the Portulaca оlеracea CO2 extract.
| No. | Retention time (min) | Compound | Identification probability (%) | Percentage (%) |
|---|---|---|---|---|
| 1 | 33.8 | Phytol | 85 | 3.6 |
| 2 | 35.0 | Ethyl oleate | 71 | 2.7 |
| 3 | 39.0 | Hexacosane | 84 | 4.1 |
| 4 | 41.4 | Octadecane, 3-ethyl-5-(2-ethylbutyl)- | 65 | 3.3 |
| 5 | 45.0 | Octacosane | 92 | 53.4 |
| 6 | 48.7 | Hentriacontane | 80 | 7.3 |
| 7 | 50.9 | Vitamin E | 89 | 13.8 |
| 8 | 54.7 |
| 80 | 11.8 |
Figure 4The ratio of the main groups of biologically active compounds of the Portulaca oleracea methanol fraction.
Change in the optical density of solutions depending on the working solutions concentration.
| No. | Samples | Optical density value at concentration (mg/ml) | |||
|---|---|---|---|---|---|
| 0.25 | 0.5 | 0.75 | 1.0 | ||
| 1 | Ascorbic acid (AA) | 1.5539 | 1.5928 | 1.6775 | 1.7738 |
| 2 | CO2 extract of | 0.1314 | 0.2659 | 0.3878 | 0.7519 |
Pharmacologically active compounds of the therapeutic value from the Portulaca оlеracea CO2 extract.
| No. | Compound | Percentage (%) | Pharmacologic effect |
|---|---|---|---|
| 1 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | 2.44 | Antidiabetic, antioxidant, antibacterial, anti-inflammatory, antifungal activity [ |
| 2 | Benzofuran, 2,3-dihydro- | 1.06 | Anti-HIV, anticancer, antibacterial, and antifungal activities [ |
| 3 | 2-Methoxy-4-vinylphenol | 2.07 | Antibacterial, anti-inflammatory [ |
| 4 | Desulphosinigrin | 16.96 | Antioxidant activity [ |
| 5 | Vitamin E | 6.42 | Antioxidant and anti-inflammatory activities [ |
Pharmacologically active compounds of therapeutic value (hexane, dichloromethane, ethyl acetate, and methanol fraction) of Portulaca оlеracea CO2 extract.
| No. | Compound | Hexane fraction | Dichloromethane fraction | Ethyl acetate fraction | Methanol fraction | Pharmacologic effect | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Percentage (%) | The presence or absence of an ingredient | Percentage (%) | The presence or absence of an ingredient | Percentage (%) | The presence or absence of an ingredient | Percentage (%) | The presence or absence of an ingredient | |||
| 1 | Vitamin E | 17.62 | + | 21.22 | + | — | — | 13.8 | + | Antioxidant and anti-inflammatory activities [ |
| 2 | Decanoic acid | 1.44 | + | − | − | − | − | − | − | Triglyceride. Antibacterial, anti-inflammatory, anticancer, and antioxidant activities [ |
| 3 | 2-Pentadecanone, 6,10,14-trimethyl | 2.87 | + | 5.33 | + | 2.71 | + | − | − | Antidiabetic potential and moderate anticholine esterase activities [ |
| 4 |
| 2.56 | + | 3.28 | + | − | − | − | − | Anti-inflammatory property [ |
| 5 | Campesterol | 4.54 | + | 4.51 | + | 5.32 | + | − | − | Phytosterols. Sterols have the ability to lower cholesterol levels. It is also effective in cancer prevention [ |
| 6 | Stigmasterol | 2.86 | + | − | − | − | − | − | − | Antimicrobial and antioxidant activities [ |
| 7 |
| 20.65 | + | 22.75 | + | 26.73 | + | 11.8 | + | Phytosterols. Sterols have the ability to lower cholesterol levels. It is also effective in cancer prevention [ |
| 8 | 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl- | — | — | 1.00 | + | — | — | — | — | Benzofuran derivatives have biological activity as an antidepressant, antitumor, antiviral, antifungal, antioxidant, antipsychotic agent [ |
| 9 | Squalene | − | − | 5.73 | + | − | − | − | − | Triterpenoid. Antioxidant, hypolipidemic, and antitoxic effects [ |
| 10 | Hexadecanoic acid 9,46 | − | − | − | − | 9.46 | + | − | − | Triglyceride. Antitumor and antihelmintic properties [ |
| 11 | DL- | − | − | − | − | 29.69 | + | − | − | Antioxidant and anti-inflammatory activities [ |
−, absence of ingredient; +, presence of ingredient.